Assignee
SCHERING CORP
US1,753 patents
Top patents by PatentIndex Score
US6821978B2Nov 23, 2004
Xanthine phosphodiesterase V inhibitors
SCHERING CORP140 citations99
US6495667B1Dec 17, 2002
Il-b30 antibodies
SCHERING CORP166 citations99
USRE37721EMay 28, 2002
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING CORP99 citations99
US6329395B1Dec 11, 2001
Neuropeptide Y5 receptor antagonists
SCHERING CORP186 citations99
US5874442AFeb 23, 1999
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
SCHERING CORP129 citations99
US5846966ADec 8, 1998
Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors
SCHERING CORP171 citations99
US5631365AMay 20, 1997
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING CORP135 citations99
US5089496AFeb 18, 1992
Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
SCHERING CORP138 citations99
US5004810AApr 2, 1991
Antiviral oligomers
SCHERING CORP174 citations99
US4929641AMay 29, 1990
Mercapto-acylamino acid antihypertensives
SCHERING CORP164 citations99
US4668240AMay 26, 1987
Pigment colored contact lenses and method for making same
SCHERING CORP151 citations99
US4587258AMay 6, 1986
Angiotensin-converting enzyme inhibitors
SCHERING CORP197 citations99
US7217796B2May 15, 2007
Neutralizing human anti-IGFR antibody
SCHERING CORP105 citations98
US7025962B1Apr 11, 2006
Mammalian cell surface antigens; related reagents
SCHERING CORP346 citations98
US6911428B2Jun 28, 2005
Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP124 citations98
US6756481B2Jun 29, 2004
IL-23 receptor binding compositions
SCHERING CORP103 citations98
US6645987B2Nov 11, 2003
Nor-seco himbacine derivatives useful as thrombin receptor antagonists
SCHERING CORP97 citations98
US6207822B1Mar 27, 2001
Process for the synthesis of azetidinones
SCHERING CORP163 citations98
US6111090AAug 29, 2000
Mammalian cell surface antigens; related reagents
SCHERING CORP351 citations98
US6066636AMay 23, 2000
Muscarinic antagonists
SCHERING CORP96 citations98
US6063847AMay 16, 2000
Thrombin receptor antagonists
SCHERING CORP180 citations98
US6057307AMay 2, 2000
Use of mometasone furoate for treating airway passage and lung diseases
SCHERING CORP118 citations98
US5977138ANov 2, 1999
Ether muscarinic antagonists
SCHERING CORP99 citations98
US5952349ASep 14, 1999
Muscarinic antagonists for treating memory loss
SCHERING CORP165 citations98
US5889015AMar 30, 1999
Use of mometasone furoate for treating lower airway passage and lung diseases
SCHERING CORP124 citations98
US5883096AMar 16, 1999
Muscarinic antagonists
SCHERING CORP164 citations98
US5861279AJan 19, 1999
Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists
SCHERING CORP137 citations98
US5856473AJan 5, 1999
Process for preparing 1-(4-fluorophenyl)-3(R)-(3(S)-hydroxy-3-( phenyl or 4-fluorophenyl!)-propyl)-4(S)-(4-hydroxyphenyl)-2-azetidinone
SCHERING CORP98 citations98
US5837699ANov 17, 1998
Use of mometasone furoate for treating upper airway passage diseases
SCHERING CORP125 citations98
US5795894AAug 18, 1998
Piperazino derivatives as neurokinn antagonists
SCHERING CORP109 citations98
US5770403AJun 23, 1998
Cloning and exprssion of humanized monoclonal antibodies against human interluekin-4
SCHERING CORP119 citations98
US5740792AApr 21, 1998
Inhaler for powdered medications with gear-teeth counter assembly
SCHERING CORP196 citations98
US5661152AAug 26, 1997
Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP137 citations98
US5112616AMay 12, 1992
Fast dissolving buccal tablet
SCHERING CORP198 citations98
US5073374ADec 17, 1991
Fast dissolving buccal tablet
SCHERING CORP188 citations98
US5017691AMay 21, 1991
Mammalian interleukin-4
SCHERING CORP242 citations98
US4659716AApr 21, 1987
Antihistaminic 8-(halo)-substituted 6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridines
SCHERING CORP145 citations98
US4582402AApr 15, 1986
Color-imparting contact lenses
SCHERING CORP175 citations98
US4450164AMay 22, 1984
Imidazo[1,2-A]pyridines and use
SCHERING CORP207 citations98
US7566718B2Jul 28, 2009
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
SCHERING CORP73 citations97
US7417045B2Aug 26, 2008
Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
SCHERING CORP64 citations97
US6838475B2Jan 4, 2005
Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP121 citations97
US6800434B2Oct 5, 2004
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP89 citations97
US6689765B2Feb 10, 2004
Piperazine derivatives useful as CCR5 antagonists
SCHERING CORP71 citations97
US6403564B1Jun 11, 2002
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
SCHERING CORP122 citations97
US6391865B1May 21, 2002
Piperazine derivatives useful as CCR5 antagonists
SCHERING CORP94 citations97
US6372747B1Apr 16, 2002
Farnesyl protein transferase inhibitors
SCHERING CORP93 citations97
US6362188B1Mar 26, 2002
Farnesyl protein transferase inhibitors
SCHERING CORP85 citations97
US6326380B1Dec 4, 2001
Thrombin receptor antagonists
SCHERING CORP103 citations97
US6277830B1Aug 21, 2001
5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
SCHERING CORP120 citations97
Showing the top 50 of 1,753 patents by PatentIndex Score.